Myeloid Lineage Differentiation and Osteoclast Priming by a Novel Pax5 Cytokine
新型 Pax5 细胞因子的骨髓谱系分化和破骨细胞启动
基本信息
- 批准号:8692538
- 负责人:
- 金额:$ 17.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2016-06-30
- 项目状态:已结题
- 来源:
- 关键词:AnimalsB cell differentiationB-LymphocytesBone MarrowBone Marrow CellsCell Differentiation processCell LineCell LineageCell ProliferationCellsCessation of lifeConditioned Culture MediaDataDatabasesDendritic CellsDevelopmentDigestionDiseaseFailureGenesGoalsGrowth FactorHematopoieticHematopoietic stem cellsImmuneImplantInflammatoryLiquid ChromatographyMaintenanceMature B-LymphocyteMusMyelogenousMyeloid CellsMyeloid Progenitor CellsOsteoclastsPathway interactionsPerformancePeriodontal DiseasesPhasePhenotypePlayPopulationProsthesisProteinsRegulationRepressionRheumatoid ArthritisRoleScienceSeriesSourceSpleenStagingStem cellsTCF3 genebonebone cellbone lossbone masscell typecytokinederepressionexperiencegranulocytemacrophagemembernovelosteoclastogenesisosteogenicprematureprogenitorpublic health relevancesubstantia spongiosatranscription factor
项目摘要
DESCRIPTION (provided by applicant): Bone marrow is the source of osteogenic, hematopoietic, and immune cells. It is now well accepted that osteoclasts, like macrophages, granulocytes and dendritic cells, are members of the myeloid lineage arising from hematopoietic stem cells. During the early stages of hematopoietic cell differentiation multipotential progenitor
(MPP) cells can give rise to either myeloid progenitors or B lymphocyte progenitors. These early cell fate decisions are regulated, in part, by the expression or repression of proteins under the control of a series of transcription factors (TFs), which include, PU.1, Ikaros, E2A, Ebf1, Pax5 and Gon4-like. With the exception of PU.1 and Ikaros the other TFs are most often associated with B cell differentiation. However, we and others have shown that some of these TFs play an important role in bone cell development. How these TFs regulate the early cell fate choice between osteoclast and B cell differentiation is however only starting to be explored but with little direct data available. This regulation takes on added significance because of data showing that immune cells can be potent regulators of osteoclast differentiation. We have begun an analysis of mice deficient in Pax5, a TF required for commitment and maintenance of the B cell lineage. These animals experience a developmental block in B cell differentiation resulting in a phenotype characterized by the absence of most B cells. Importantly, these mice are also severely runted; they develop strikingly decreased trabecular bone mass with markedly increased numbers of osteoclasts. We have been able to isolate and characterize an adherent cell population from the spleen of Pax5-/- mice that grows continuously in culture without added growth factors and can give rise to osteoclasts, macrophages and dendritic cells. In addition, these cells secrete a cytokine(s) that induces proliferation and primes wild-type cells to also become myeloid progenitor cells. It is our hypothesis that the loss of Pax5 leads to the derepression of specific genes that allow the secretion of this novel cytokine(s), which induces myeloid progenitor cell differentiation resulting in increased osteoclastogenesis and this in turn produces the resultant bone phenotype. In broader terms, loss of Pax5 may have revealed a new pathway that regulates myeloid cell differentiation and specifically osteoclasts. The goal of this proposal is to identify that cytokine(s) and thus the mechanism(s) by which Pax5 regulates myeloid cell differentiation.
描述(由申请人提供):骨髓是成骨,造血和免疫细胞的来源。现在可以很好地接受的是,巨噬细胞,粒细胞和树突状细胞等破骨细胞是由造血干细胞引起的髓样谱系的成员。在造血细胞分化多能祖细胞的早期阶段
(MPP)细胞可以引起髓样祖细胞或B淋巴细胞祖细胞。这些早期的细胞命运决定部分通过在一系列转录因子(TFS)的控制下的表达或抑制来调节,其中包括PU.1,Ikaros,E2A,E2A,EBF1,PAX5,PAX5和GON4样。除了PU.1和Ikaros外,其他TF通常与B细胞分化有关。但是,我们和其他人表明,其中一些TF在骨细胞发育中起着重要作用。然而,这些TF如何调节破骨细胞和B细胞分化之间的早期细胞命运选择才被开始探索,但几乎没有直接数据可用。由于数据表明免疫细胞可以是破骨细胞分化的有效调节剂,因此该调节具有附加意义。我们已经开始对缺乏PAX5的小鼠进行分析,PAX5是B细胞谱系的承诺和维持所需的TF。这些动物在B细胞分化中经历了发育障碍,导致表型,其特征是大多数B细胞的缺乏。重要的是,这些小鼠也被严重运行。他们随着破骨细胞数量的明显增加而产生的小梁骨量显着降低。我们已经能够与Pax5 - / - 小鼠的脾脏中的粘附细胞群隔离并表征,这些细胞群在培养中不断生长而没有增加生长因子,并可能引起破骨细胞,巨噬细胞和树突状细胞。此外,这些细胞分泌一种细胞因子,该细胞因子诱导增殖和素型野生型细胞也成为髓样祖细胞。我们的假设是,PAX5的丧失导致了特定基因的压抑,该基因允许这种新型细胞因子的分泌,从而诱导髓样祖细胞分化,从而导致骨质造成骨质发生的增加,并且这会产生所得的骨骼表型。从更广泛的角度来看,PAX5的丧失可能揭示了一种调节髓样细胞分化,特别是破骨细胞的新途径。该建议的目的是确定细胞因子,从而确定PAX5调节髓样细胞分化的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK C HOROWITZ其他文献
MARK C HOROWITZ的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK C HOROWITZ', 18)}}的其他基金
The Sixth International Conference on Osteoimmunology: Interactions of the Immune and Skeletal Systems
第六届国际骨免疫学会议:免疫与骨骼系统的相互作用
- 批准号:
9117878 - 财政年份:2016
- 资助金额:
$ 17.69万 - 项目类别:
The Fifth International Conference on Osteoimmunology: Interactions of the Immune
第五届国际骨免疫学会议:免疫的相互作用
- 批准号:
8709156 - 财政年份:2014
- 资助金额:
$ 17.69万 - 项目类别:
Myeloid Lineage Differentiation and Osteoclast Priming by a Novel Pax5 Cytokine
新型 Pax5 细胞因子的骨髓谱系分化和破骨细胞启动
- 批准号:
8581522 - 财政年份:2013
- 资助金额:
$ 17.69万 - 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
- 批准号:
8328698 - 财政年份:2011
- 资助金额:
$ 17.69万 - 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
- 批准号:
8698743 - 财政年份:2011
- 资助金额:
$ 17.69万 - 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
- 批准号:
8496032 - 财政年份:2011
- 资助金额:
$ 17.69万 - 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism & Energy Balance
骨髓肥胖、矿物质代谢的跨学科研究
- 批准号:
8183483 - 财政年份:2011
- 资助金额:
$ 17.69万 - 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism, and Energy Balance
骨髓肥胖、矿物质代谢和能量平衡的跨学科研究
- 批准号:
9769004 - 财政年份:2011
- 资助金额:
$ 17.69万 - 项目类别:
Interdisciplinary Study of Marrow Adiposity, Mineral Metabolism, and Energy Balance
骨髓肥胖、矿物质代谢和能量平衡的跨学科研究
- 批准号:
8967832 - 财政年份:2011
- 资助金额:
$ 17.69万 - 项目类别:
相似国自然基金
Hippo信号通路调控B淋巴细胞分化在狼疮肾炎中的作用与机制研究
- 批准号:82302023
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
海量批次单细胞数据整合挖掘急性B淋巴细胞白血病分化阻滞机制的研究
- 批准号:32370722
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
肠道微生态紊乱通过SCFAs介导B淋巴细胞分化及功能障碍在COVID-19中作用和机制
- 批准号:82241044
- 批准年份:2022
- 资助金额:62.00 万元
- 项目类别:专项项目
MEF2D融合基因在B-ALL中的致病机制研究
- 批准号:81800140
- 批准年份:2018
- 资助金额:21.0 万元
- 项目类别:青年科学基金项目
mTORC1通路在B1a细胞命运决定中的作用及其分子调控机制研究
- 批准号:31770960
- 批准年份:2017
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
- 批准号:
10574346 - 财政年份:2023
- 资助金额:
$ 17.69万 - 项目类别:
Determinants of HIV broadly-neutralizing antibody precursor induction in infants
婴儿中 HIV 广泛中和抗体前体诱导的决定因素
- 批准号:
10731276 - 财政年份:2023
- 资助金额:
$ 17.69万 - 项目类别:
Project 3: Defining adaptive immune interactions that shape Clostridioides difficile infection
项目 3:定义影响艰难梭菌感染的适应性免疫相互作用
- 批准号:
10625579 - 财政年份:2023
- 资助金额:
$ 17.69万 - 项目类别:
Development of an Inducible Conditional Gene Deletion Mouse Model to Study Plasma Cell Development and Longevity
开发可诱导条件基因缺失小鼠模型来研究浆细胞发育和寿命
- 批准号:
10452247 - 财政年份:2022
- 资助金额:
$ 17.69万 - 项目类别: